Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Access Consortium regulators pledge support to tackle COVID-19 The Access Consortium regulatory authorities Footnote 1 have pledged our collective support in countering the COVID-19 global pandemic. To address this worldwide public health crisis, Access Consortium members are…
Joint Statement on Clinical Trial Oversight in Canada Health Canada - Canadian Institutes of Health Research - Canadian Association of Research Ethics Boards Published: May 27, 2020 Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration…
Depuis mars 2020, les IRSC ont investi environ 414 millions de dollars dans 965 projets de recherche sur la COVID-19.
ARCHIVED Applications for COVID-19 drug and medical device clinical trials under the Interim Order: Notice release of guidance documents Notice to Reader: We have replaced the Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19. See…
ARCHIVED Interim Order respecting clinical trials for medical devices and drugs relating to COVID-19: Notice Notice to Reader: We have replaced the Interim Order No. 2 respecting clinical trials for medical devices and drugs relating to COVID-19. See the regulations notice about…
Changes to notification requirements for biologic drugs: Notice to industry Health Canada is reducing the administrative burden to help clinical trial sponsors and market authorization holders efficiently distribute treatments. On this page Purpose and background Measures to…
Prescription Drug List (PDL): Remdesivir (COVID-19) notice Date published: July 28, 2020 Our file number: 20-110364-67 The purpose of this Notice of Amendment is to notify about the addition of remdesivir to the Prescription Drug List (PDL) for human and veterinary use. The new…
Order to extend review period for clinical trial applications and amendments: Notice Date published: August 14, 2020 On August 13, 2020, the Minister of Health approved an order to temporarily extend the default period to review clinical trial applications and amendments . This…
ARCHIVED Interim order and guidance document to import, sell and advertise COVID-19 related drugs and vaccines: Notice COVID-19 drugs that were authorized in Canada under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19…
Archived: Public release of clinical information for drugs and medical devices in COVID-19 interim orders applications: Guidance On February 22, 2023, Health Canada introduced the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation…
Page 4298 sur 6399Affichage de 42971 à 42980 sur 63986
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
